---

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15 (d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

November 30, 2005

 

FMC CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware		1-2376		94-0479804
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

1735 Market Street, Philadelphia, PA 19103

(Address of principal executive offices) (Zip Code)

 

(215) 299-6000

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act

 

¨	Soliciting material pursuant to Rule 14a-2 under the Exchange Act

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

---

---

ITEM 7.01.

Regulation FD Disclosure.

 

On November 30, 2005, William G. Walter, Chairman of the Board, President and Chief Executive Officer, had a presentation at the Morgan Stanley Small Cap Chemicals Roundtable in New York, New York. Slides used in his presentation at the meetings are included herein as an exhibit. These slides may also be accessed at the company’s website (www.fmc.com) and will be available for a period of at least thirty days.

 

This report is not deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

 

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS.

 

(c)

Exhibits:

 

99.1		Slides used by William G. Walter, Chairman of the Board, President and Chief Executive Officer, in his presentation at the Morgan Stanley Small Cap Chemicals Roundtable in New York, New York on November 30, 2005.

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Date: December 2, 2005

---

EXHIBIT INDEX

 

Exhibit   Number		Description
99.1		Slides used by William G. Walter, Chairman of the Board, President and Chief Executive Officer, in his presentation at the Morgan Stanley Small Cap Chemicals Roundtable in New York, New York on November 30, 2005.